BiotechTube

Tissucol®

Pre-clinicalCompleted
0 views this week 0 watching💤 Quiet
Interest: 23/100
23
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Femoral Vascular Anastomosis

Conditions

Femoral Vascular Anastomosis

Trial Timeline

Sep 1, 2003 → Feb 1, 2004

NCT ID
NCT00163592

About Tissucol®

Tissucol® is a pre-clinical stage product being developed by Baxter for Femoral Vascular Anastomosis. The current trial status is completed. This product is registered under clinical trial identifier NCT00163592. Target conditions include Femoral Vascular Anastomosis.

What happened to similar drugs?

1 of 3 similar drugs in Femoral Vascular Anastomosis were approved

Approved (1) Terminated (0) Active (2)
✅Tranexamic Acid plus standard of carePfizerApproved
🔄Teriparatide 20 mcgEli LillyPhase 3
🔄zoledronic acid (aclasta)NovartisPhase 3

Hype Score Breakdown

Clinical
3
Activity
8
Company
12
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00163592Pre-clinicalCompleted

Competing Products

3 competing products in Femoral Vascular Anastomosis

See all competitors
ProductCompanyStageHype Score
Teriparatide 20 mcgEli LillyPhase 3
40
zoledronic acid (aclasta)NovartisPhase 3
40
Tranexamic Acid plus standard of carePfizerApproved
43